Cargando…
Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection
We have shown that two weakly immunogenic MCA sarcomas developed in our laboratory that are sensitive to high-dose IL-2 immunotherapy express class I MHC in vivo and in vitro. Two nonimmunogenic MCA sarcomas are relatively insensitive to IL-2 therapy and express minimal or no class I MHC molecules i...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188791/ https://www.ncbi.nlm.nih.gov/pubmed/3500265 |
Ejemplares similares
-
Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection.
por: Mongini, C., et al.
Publicado: (1996) -
A transient transfection system for identifying biosynthesized proteins processed and presented to class I MHC restricted T lymphocytes
por: Eisenlohr, Laurence C., et al.
Publicado: (1992) -
The urgent need to recover MHC class I in cancers for effective immunotherapy
por: Garrido, Federico, et al.
Publicado: (2016) -
A tissue-based draft map of the murine MHC class I immunopeptidome
por: Schuster, Heiko, et al.
Publicado: (2018) -
MHC class I multimers
por: Sun, Mei-Yi, et al.
Publicado: (2001)